• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Axonics Inc (NQ: AXNX )

    70.37 +0.07 (+0.10%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Axonics Inc

    < Previous 1 2 3 Next >
    Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
    From Axonics, Inc.
    Via Business Wire
    Axonics Prevails in Patent Infringement Lawsuit with Medtronic
    From Axonics, Inc.
    Via Business Wire
    Axonics Reports Second Quarter 2024 Financial Results
    From Axonics, Inc.
    Via Business Wire
    Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
    From Axonics, Inc.
    Via Business Wire
    Axonics Reports First Quarter 2024 Financial Results
    From Axonics, Inc.
    Via Business Wire
    Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
    Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. 
    Via MarketBeat
    Axonics Stockholders Approve Merger Agreement with Boston Scientific
    From Axonics, Inc.
    Via Business Wire
    Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
    From Axonics, Inc.
    Via Business Wire
    Axonics Responds to ITC Action by Medtronic
    From Axonics, Inc.
    Via Business Wire
    Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
    From Axonics, Inc.
    Via Business Wire
    AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    AXNX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Axonics, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
    From Axonics, Inc.
    Via Business Wire
    Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
    From Axonics, Inc.
    Via Business Wire
    Axonics to Present at the J.P. Morgan Healthcare Conference
    From Axonics, Inc.
    Via Business Wire
    Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities
    From NeuroQure
    Via GlobeNewswire
    Axonics to Participate in November Investor Conferences
    From Axonics, Inc.
    Via Business Wire
    Axonics Reports Third Quarter 2023 Financial Results
    From Axonics, Inc.
    Via Business Wire
    Axonics to Report Third Quarter 2023 Financial Results on October 30
    From Axonics, Inc.
    Via Business Wire
    Axonics to Participate in September Investor Conferences
    From Axonics, Inc.
    Via Business Wire
    Axonics Announces CFO Retirement and Appoints Successor
    From Axonics, Inc.
    Via Business Wire
    Axonics Reports Second Quarter 2023 Financial Results
    From Axonics, Inc.
    Via Business Wire
    Axonics to Report Second Quarter 2023 Financial Results on July 27
    From Axonics, Inc.
    Via Business Wire
    Axonics Reports First Quarter 2023 Financial Results
    From Axonics, Inc.
    Via Business Wire
    Axonics to Participate in Upcoming Investor Conferences
    From Axonics, Inc.
    Via Business Wire
    Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation
    From Axonics, Inc.
    Via Business Wire
    Axonics to Report First Quarter 2023 Financial Results on May 1
    From Axonics, Inc.
    Via Business Wire
    Axonics Ranked No. 2 on the Financial Times 2023 List of the Fastest Growing Companies in the Americas
    From Axonics, Inc.
    Via Business Wire
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.